| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | V00Y10W60W |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| OTHER | Myeloid cell surface antigen CD33 other | PubMed |
| Primary Target | |
|---|---|
| CD33 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Leukemia | 3 | D007938 | ClinicalTrials |
| Myelodysplastic Syndromes | 2 | D009190 | ClinicalTrials |
| Leukemia, Myeloid, Acute | 2 | D015470 | ClinicalTrials |
| Neutropenia | 2 | D009503 | ClinicalTrials |
| Multiple Myeloma | 1 | D009101 | ClinicalTrials |
| Leukemia, Myelomonocytic, Chronic | 1 | D015477 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 166089-32-3 |
| ChEMBL | CHEMBL2109150 |
| FDA SRS | V00Y10W60W |
| Guide to Pharmacology | 7983 |
CONTENTS